138 related articles for article (PubMed ID: 16075925)
1. Poorly specific binding of thyroglobulin to orbital fibroblasts from patients with Graves' ophthalmopathy.
Lisi S; Botta R; Agretti P; Sellari-Franceschini S; Marcocci C; Pinchera A; Marinò M
J Endocrinol Invest; 2005 May; 28(5):420-4. PubMed ID: 16075925
[TBL] [Abstract][Full Text] [Related]
2. Role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy: the hypothesis of Kriss revisited.
Marinò M; Chiovato L; Lisi S; Altea MA; Marcocci C; Pinchera A
J Endocrinol Invest; 2004 Mar; 27(3):230-6. PubMed ID: 15164998
[TBL] [Abstract][Full Text] [Related]
3. Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders.
Kuroki T; Ruf J; Whelan L; Miller A; Wall JR
Clin Exp Immunol; 1985 Nov; 62(2):361-70. PubMed ID: 3841305
[TBL] [Abstract][Full Text] [Related]
4. Identification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy.
Marinò M; Lisi S; Pinchera A; Mazzi B; Latrofa F; Sellari-Franceschini S; McCluskey RT; Chiovato L
Thyroid; 2001 Feb; 11(2):177-85. PubMed ID: 11288989
[TBL] [Abstract][Full Text] [Related]
5. Glycosaminoglycans provide a binding site for thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy.
Marinò M; Lisi S; Pinchera A; Marcocci C; Menconi F; Morabito E; Macchia M; Sellari-Franceschini S; McCluskey RT; Chiovato L
Thyroid; 2003 Sep; 13(9):851-9. PubMed ID: 14588099
[TBL] [Abstract][Full Text] [Related]
6. Thyroglobulin in orbital tissues from patients with thyroid-associated ophthalmopathy: predominant localization in fibroadipose tissue.
Lisi S; Marinò M; Pinchera A; Mazzi B; Di Cosmo C; Sellari-Franceschini S; Chiovato L
Thyroid; 2002 May; 12(5):351-60. PubMed ID: 12097194
[TBL] [Abstract][Full Text] [Related]
7. Use of monoclonal antibodies to investigate a possible role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy.
Kodama K; Sikorska H; Bayly R; Bandy-Dafoe P; Wall JR
J Clin Endocrinol Metab; 1984 Jul; 59(1):67-73. PubMed ID: 6327760
[TBL] [Abstract][Full Text] [Related]
8. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to IGF-1 binding sites in thyroid associated ophthalmopathy.
Weightman DR; Perros P; Sherif IH; Kendall-Taylor P
Autoimmunity; 1993; 16(4):251-7. PubMed ID: 7517705
[TBL] [Abstract][Full Text] [Related]
10. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
Dik WA; Virakul S; van Steensel L
Exp Eye Res; 2016 Jan; 142():83-91. PubMed ID: 26675405
[TBL] [Abstract][Full Text] [Related]
11. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy.
Bahn RS; Dutton CM; Natt N; Joba W; Spitzweg C; Heufelder AE
J Clin Endocrinol Metab; 1998 Mar; 83(3):998-1002. PubMed ID: 9506762
[TBL] [Abstract][Full Text] [Related]
12. Studies of retroorbital tissue xenografts from patients with Graves' ophthalmopathy in severe combined immunodeficient (SCID) mice: detection of thyroid-stimulating antibody.
Mori S; Yoshikawa N; Tokoro T; Ikehara S; Inoue Y; Nishikawa M; Inada M
Thyroid; 1996 Aug; 6(4):275-81. PubMed ID: 8875746
[TBL] [Abstract][Full Text] [Related]
13. Orbital fibroblasts exhibit a novel pattern of responses to proinflammatory cytokines: potential basis for the pathogenesis of thyroid-associated ophthalmopathy.
Smith TJ
Thyroid; 2002 Mar; 12(3):197-203. PubMed ID: 11952039
[TBL] [Abstract][Full Text] [Related]
14. Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle.
Mullin BR; Levinson RE; Friedman A; Henson DE; Winand RJ; Kohn LD
Endocrinology; 1977 Feb; 100(2):351-66. PubMed ID: 401730
[TBL] [Abstract][Full Text] [Related]
15. Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy--roles of class II MHC antigen expression and gamma-interferon action of effector and target cells.
Hiromatsu Y; Fukazawa H; How J; Wall JR
Clin Exp Immunol; 1987 Dec; 70(3):593-603. PubMed ID: 3124997
[TBL] [Abstract][Full Text] [Related]
16. Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy.
Khoo TK; Coenen MJ; Schiefer AR; Kumar S; Bahn RS
Thyroid; 2008 Dec; 18(12):1291-6. PubMed ID: 18976167
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin class and subclass distribution of eye muscle and fibroblast antibodies in patients with thyroid-associated ophthalmopathy.
Tandon N; Yan SL; Arnold K; Metcalfe RA; Weetman AP
Clin Endocrinol (Oxf); 1994 May; 40(5):629-39. PubMed ID: 8013144
[TBL] [Abstract][Full Text] [Related]
18. Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy.
Feldon SE; Park DJ; O'Loughlin CW; Nguyen VT; Landskroner-Eiger S; Chang D; Thatcher TH; Phipps RP
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3913-21. PubMed ID: 16249464
[TBL] [Abstract][Full Text] [Related]
19. Graves' ophthalmopathy.
Wall JR; Henderson J; Strakosch CR; Joyner DM
Can Med Assoc J; 1981 Apr; 124(7):855-62, 866. PubMed ID: 7011529
[TBL] [Abstract][Full Text] [Related]
20. New understanding of the role of cytokines in the pathogenesis of Graves' ophthalmopathy.
Ajjan RA; Weetman AP
J Endocrinol Invest; 2004 Mar; 27(3):237-45. PubMed ID: 15164999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
